|
Maple syrup urine disease, type 1B
|
C535711 |
|
|
Maple syrup urine disease, type 2
|
C535712 |
|
|
Opitz Reynolds Fitzgerald syndrome
|
C535713 |
|
|
Neuropathy, congenital, with arthrogryposis multiplex
|
C535714 |
|
|
Spinal muscular atrophy, Jerash type
|
C535715 |
|
|
2-(3-(4-(2-quinolyl))-1-piperazinyl)propyl-1,2,4-triazolo(4,3-a)pyridin-3(2H)-one
|
C075476 |
|
|
ochratoxin A hydroxylase
|
C075477 |
|
|
LY 266070
|
C075479 |
|
|
Daish Hardman Lamont syndrome
|
C535770 |
|
|
Dandy Walker malformation postaxial polydactyly
|
C535771 |
|
|
Dandy Walker variant
|
C535772 |
|
|
Mental retardation, X-linked, syndromic 5
|
C535773 |
|
|
AG-01 compound
|
C521122 |
|
|
PVT1 long-non-coding RNA, human
|
C521123 |
|
|
marinobactin E
|
C521124 |
|
|
diamminediethyldithiocarbamato-platinum (II) nitrate
|
C075470 |
|
|
1,3-difluoroallene
|
C521125 |
|
|
2,2'-bipyridine-alpha,alpha'-diaminosuberic acid platinum(II)
|
C075471 |
|
|
AFAP1L2 protein, human
|
C521126 |
|
|
2,2'-bipyridine-alpha,alpha'-diaminoadipic acid platinum(II)
|
C075472 |
|
